Loading clinical trials...
Loading clinical trials...
Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep: A Randomized, Double-Blind, Placebo- Controlled Study
Conditions
Interventions
Lemborexant 10 mg
Naltrexone
Locations
1
United States
The Menninger Clinic
Houston, Texas, United States
Start Date
February 9, 2023
Primary Completion Date
January 30, 2024
Completion Date
January 30, 2024
Last Updated
March 24, 2026
NCT07027839
NCT06552741
NCT07279558
NCT07341230
NCT05855668
NCT06985927
Lead Sponsor
Baylor College of Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions